GO:0008595 | anterior/posterior axis specification, embryo | 33.33% (1/3) | 10.67 | 0.000614 | 0.010927 |
GO:0008190 | eukaryotic initiation factor 4E binding | 33.33% (1/3) | 10.5 | 0.000691 | 0.011175 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 33.33% (1/3) | 10.5 | 0.000691 | 0.011175 |
GO:0030891 | VCB complex | 33.33% (1/3) | 10.86 | 0.000537 | 0.011249 |
GO:1902498 | regulation of protein autoubiquitination | 33.33% (1/3) | 10.86 | 0.000537 | 0.011249 |
GO:0008134 | transcription factor binding | 66.67% (2/3) | 5.55 | 0.000605 | 0.011326 |
GO:0021795 | cerebral cortex cell migration | 33.33% (1/3) | 11.08 | 0.00046 | 0.011708 |
GO:0021799 | cerebral cortex radially oriented cell migration | 33.33% (1/3) | 11.08 | 0.00046 | 0.011708 |
GO:0021885 | forebrain cell migration | 33.33% (1/3) | 11.08 | 0.00046 | 0.011708 |
GO:0022029 | telencephalon cell migration | 33.33% (1/3) | 11.08 | 0.00046 | 0.011708 |
GO:0061663 | NEDD8 ligase activity | 33.33% (1/3) | 11.08 | 0.00046 | 0.011708 |
GO:0010498 | proteasomal protein catabolic process | 66.67% (2/3) | 5.56 | 0.000594 | 0.011743 |
GO:0030163 | protein catabolic process | 66.67% (2/3) | 5.37 | 0.000775 | 0.01199 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 66.67% (2/3) | 5.68 | 0.000505 | 0.011993 |
GO:0019788 | NEDD8 transferase activity | 33.33% (1/3) | 10.08 | 0.000921 | 0.01214 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 33.33% (1/3) | 10.08 | 0.000921 | 0.01214 |
GO:0034450 | ubiquitin-ubiquitin ligase activity | 33.33% (1/3) | 10.08 | 0.000921 | 0.01214 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 33.33% (1/3) | 10.21 | 0.000844 | 0.01252 |
GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 33.33% (1/3) | 9.35 | 0.001534 | 0.013005 |
GO:0045116 | protein neddylation | 33.33% (1/3) | 9.35 | 0.001534 | 0.013005 |
GO:1901995 | positive regulation of meiotic cell cycle phase transition | 33.33% (1/3) | 9.35 | 0.001534 | 0.013005 |
GO:1902104 | positive regulation of metaphase/anaphase transition of meiotic cell cycle | 33.33% (1/3) | 9.35 | 0.001534 | 0.013005 |
GO:1905134 | positive regulation of meiotic chromosome separation | 33.33% (1/3) | 9.35 | 0.001534 | 0.013005 |
GO:0019941 | modification-dependent protein catabolic process | 66.67% (2/3) | 5.14 | 0.001063 | 0.013051 |
GO:0051059 | NF-kappaB binding | 33.33% (1/3) | 9.21 | 0.001688 | 0.013351 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 33.33% (1/3) | 9.21 | 0.001688 | 0.013351 |
GO:1900077 | negative regulation of cellular response to insulin stimulus | 33.33% (1/3) | 9.21 | 0.001688 | 0.013351 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 66.67% (2/3) | 5.14 | 0.001052 | 0.013372 |
GO:0007519 | skeletal muscle tissue development | 33.33% (1/3) | 9.03 | 0.001918 | 0.013385 |
GO:0051305 | chromosome movement towards spindle pole | 33.33% (1/3) | 9.03 | 0.001918 | 0.013385 |
GO:1902102 | regulation of metaphase/anaphase transition of meiotic cell cycle | 33.33% (1/3) | 9.03 | 0.001918 | 0.013385 |
GO:1905132 | regulation of meiotic chromosome separation | 33.33% (1/3) | 9.03 | 0.001918 | 0.013385 |
GO:0005680 | anaphase-promoting complex | 33.33% (1/3) | 8.86 | 0.002148 | 0.013413 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 33.33% (1/3) | 8.86 | 0.002148 | 0.013413 |
GO:1901993 | regulation of meiotic cell cycle phase transition | 33.33% (1/3) | 8.86 | 0.002148 | 0.013413 |
GO:0043632 | modification-dependent macromolecule catabolic process | 66.67% (2/3) | 5.08 | 0.001142 | 0.013546 |
GO:0034515 | proteasome storage granule | 33.33% (1/3) | 8.91 | 0.002071 | 0.013652 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 33.33% (1/3) | 8.91 | 0.002071 | 0.013652 |
GO:0014041 | regulation of neuron maturation | 33.33% (1/3) | 8.91 | 0.002071 | 0.013652 |
GO:0009948 | anterior/posterior axis specification | 33.33% (1/3) | 9.67 | 0.001228 | 0.013656 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 33.33% (1/3) | 9.67 | 0.001228 | 0.013656 |
GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 33.33% (1/3) | 8.72 | 0.002377 | 0.013875 |
GO:1903431 | positive regulation of cell maturation | 33.33% (1/3) | 8.72 | 0.002377 | 0.013875 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 33.33% (1/3) | 8.76 | 0.002301 | 0.013883 |
GO:0044265 | cellular macromolecule catabolic process | 66.67% (2/3) | 4.59 | 0.002267 | 0.013913 |
GO:0051603 | proteolysis involved in protein catabolic process | 66.67% (2/3) | 4.91 | 0.001459 | 0.01404 |
GO:0044093 | positive regulation of molecular function | 66.67% (2/3) | 4.99 | 0.001307 | 0.014095 |
GO:0014042 | positive regulation of neuron maturation | 33.33% (1/3) | 9.08 | 0.001841 | 0.014247 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 33.33% (1/3) | 8.63 | 0.002531 | 0.0143 |
GO:0043687 | post-translational protein modification | 33.33% (1/3) | 8.63 | 0.002531 | 0.0143 |
GO:0032991 | protein-containing complex | 100.0% (3/3) | 3.02 | 0.001888 | 0.014301 |
GO:1904799 | regulation of neuron remodeling | 33.33% (1/3) | 9.42 | 0.001458 | 0.014414 |
GO:1904801 | positive regulation of neuron remodeling | 33.33% (1/3) | 9.42 | 0.001458 | 0.014414 |
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 33.33% (1/3) | 9.5 | 0.001381 | 0.014459 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 33.33% (1/3) | 8.58 | 0.002607 | 0.014503 |
GO:0008637 | apoptotic mitochondrial changes | 33.33% (1/3) | 8.42 | 0.002914 | 0.014818 |
GO:1900076 | regulation of cellular response to insulin stimulus | 33.33% (1/3) | 8.42 | 0.002914 | 0.014818 |
GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 33.33% (1/3) | 8.5 | 0.002761 | 0.01489 |
GO:1903429 | regulation of cell maturation | 33.33% (1/3) | 8.5 | 0.002761 | 0.01489 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 33.33% (1/3) | 8.46 | 0.002837 | 0.015075 |
GO:1901565 | organonitrogen compound catabolic process | 66.67% (2/3) | 4.41 | 0.002892 | 0.015141 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 33.33% (1/3) | 11.35 | 0.000384 | 0.015178 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 33.33% (1/3) | 11.35 | 0.000384 | 0.015178 |
GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (3/3) | 2.78 | 0.003082 | 0.015237 |
GO:0030017 | sarcomere | 33.33% (1/3) | 8.35 | 0.003067 | 0.015378 |
GO:0046626 | regulation of insulin receptor signaling pathway | 33.33% (1/3) | 8.28 | 0.00322 | 0.015491 |
GO:1901797 | negative regulation of signal transduction by p53 class mediator | 33.33% (1/3) | 8.28 | 0.00322 | 0.015491 |
GO:0021535 | cell migration in hindbrain | 33.33% (1/3) | 11.67 | 0.000307 | 0.015612 |
GO:0021932 | hindbrain radial glia guided cell migration | 33.33% (1/3) | 11.67 | 0.000307 | 0.015612 |
GO:0021942 | radial glia guided migration of Purkinje cell | 33.33% (1/3) | 11.67 | 0.000307 | 0.015612 |
GO:0043224 | nuclear SCF ubiquitin ligase complex | 33.33% (1/3) | 11.67 | 0.000307 | 0.015612 |
GO:1902499 | positive regulation of protein autoubiquitination | 33.33% (1/3) | 11.67 | 0.000307 | 0.015612 |
GO:0000152 | nuclear ubiquitin ligase complex | 33.33% (1/3) | 8.05 | 0.003756 | 0.017366 |
GO:0006508 | proteolysis | 66.67% (2/3) | 4.23 | 0.00368 | 0.017469 |
GO:0080090 | regulation of primary metabolic process | 100.0% (3/3) | 2.69 | 0.003743 | 0.017534 |
GO:0060255 | regulation of macromolecule metabolic process | 100.0% (3/3) | 2.66 | 0.003947 | 0.017785 |
GO:0000153 | cytoplasmic ubiquitin ligase complex | 33.33% (1/3) | 8.0 | 0.003909 | 0.017842 |
GO:0009057 | macromolecule catabolic process | 66.67% (2/3) | 4.15 | 0.004112 | 0.018072 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 33.33% (1/3) | 7.94 | 0.004062 | 0.018077 |
GO:0140513 | nuclear protein-containing complex | 66.67% (2/3) | 4.13 | 0.004229 | 0.01836 |
GO:0031323 | regulation of cellular metabolic process | 100.0% (3/3) | 2.62 | 0.004339 | 0.018387 |
GO:0060537 | muscle tissue development | 33.33% (1/3) | 7.86 | 0.004292 | 0.018409 |
GO:0019915 | lipid storage | 33.33% (1/3) | 7.79 | 0.004522 | 0.018502 |
GO:0045879 | negative regulation of smoothened signaling pathway | 33.33% (1/3) | 7.79 | 0.004522 | 0.018502 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 33.33% (1/3) | 7.76 | 0.004598 | 0.018601 |
GO:0097602 | cullin family protein binding | 33.33% (1/3) | 7.81 | 0.004445 | 0.018617 |
GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 33.33% (1/3) | 7.69 | 0.004828 | 0.019096 |
GO:1905820 | positive regulation of chromosome separation | 33.33% (1/3) | 7.69 | 0.004828 | 0.019096 |
GO:0051446 | positive regulation of meiotic cell cycle | 33.33% (1/3) | 7.67 | 0.004904 | 0.019185 |
GO:0000082 | G1/S transition of mitotic cell cycle | 33.33% (1/3) | 7.63 | 0.005057 | 0.019358 |
GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 33.33% (1/3) | 7.63 | 0.005057 | 0.019358 |
GO:0010950 | positive regulation of endopeptidase activity | 33.33% (1/3) | 7.58 | 0.00521 | 0.019732 |
GO:0044843 | cell cycle G1/S phase transition | 33.33% (1/3) | 7.52 | 0.005439 | 0.020384 |
GO:0010952 | positive regulation of peptidase activity | 33.33% (1/3) | 7.46 | 0.005669 | 0.021022 |
GO:0031369 | translation initiation factor binding | 33.33% (1/3) | 7.44 | 0.005745 | 0.021086 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 33.33% (1/3) | 7.4 | 0.005898 | 0.021426 |
GO:0005654 | nucleoplasm | 66.67% (2/3) | 3.87 | 0.006063 | 0.021801 |
GO:0008589 | regulation of smoothened signaling pathway | 33.33% (1/3) | 7.35 | 0.006128 | 0.021814 |
GO:0097193 | intrinsic apoptotic signaling pathway | 33.33% (1/3) | 7.28 | 0.006433 | 0.022676 |
GO:0035196 | miRNA processing | 33.33% (1/3) | 7.23 | 0.006663 | 0.023254 |
GO:0016592 | mediator complex | 33.33% (1/3) | 7.21 | 0.006739 | 0.023292 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 33.33% (1/3) | 7.19 | 0.006815 | 0.02333 |
GO:0050000 | chromosome localization | 33.33% (1/3) | 7.13 | 0.007121 | 0.023692 |
GO:0000578 | embryonic axis specification | 33.33% (1/3) | 7.15 | 0.007045 | 0.023884 |
GO:0019222 | regulation of metabolic process | 100.0% (3/3) | 2.38 | 0.007116 | 0.023898 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 33.33% (1/3) | 7.1 | 0.007274 | 0.023976 |
GO:0030178 | negative regulation of Wnt signaling pathway | 33.33% (1/3) | 6.97 | 0.007961 | 0.024644 |
GO:0045664 | regulation of neuron differentiation | 33.33% (1/3) | 6.97 | 0.007961 | 0.024644 |
GO:1901796 | regulation of signal transduction by p53 class mediator | 33.33% (1/3) | 6.97 | 0.007961 | 0.024644 |
GO:0016363 | nuclear matrix | 33.33% (1/3) | 7.03 | 0.007656 | 0.024776 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 33.33% (1/3) | 7.03 | 0.007656 | 0.024776 |
GO:0065009 | regulation of molecular function | 66.67% (2/3) | 3.68 | 0.007785 | 0.024969 |
GO:0070936 | protein K48-linked ubiquitination | 33.33% (1/3) | 6.98 | 0.007885 | 0.025062 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 33.33% (1/3) | 6.91 | 0.008266 | 0.025369 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 33.33% (1/3) | 6.9 | 0.008343 | 0.025384 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 33.33% (1/3) | 6.85 | 0.008648 | 0.02609 |
GO:0033045 | regulation of sister chromatid segregation | 33.33% (1/3) | 6.84 | 0.008724 | 0.026099 |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | 33.33% (1/3) | 6.82 | 0.008801 | 0.026108 |
GO:1905818 | regulation of chromosome separation | 33.33% (1/3) | 6.8 | 0.008953 | 0.026341 |
GO:0031398 | positive regulation of protein ubiquitination | 33.33% (1/3) | 6.79 | 0.009029 | 0.026348 |
GO:0009798 | axis specification | 33.33% (1/3) | 6.7 | 0.009563 | 0.027456 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 33.33% (1/3) | 6.7 | 0.009563 | 0.027456 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 33.33% (1/3) | 6.6 | 0.01025 | 0.028286 |
GO:0000165 | MAPK cascade | 33.33% (1/3) | 6.61 | 0.010173 | 0.028294 |
GO:0051445 | regulation of meiotic cell cycle | 33.33% (1/3) | 6.61 | 0.010173 | 0.028294 |
GO:0097190 | apoptotic signaling pathway | 33.33% (1/3) | 6.64 | 0.010021 | 0.028313 |
GO:0006513 | protein monoubiquitination | 33.33% (1/3) | 6.65 | 0.009945 | 0.028322 |
GO:0044772 | mitotic cell cycle phase transition | 33.33% (1/3) | 6.57 | 0.010478 | 0.028475 |
GO:0051983 | regulation of chromosome segregation | 33.33% (1/3) | 6.58 | 0.010402 | 0.028485 |
GO:0019005 | SCF ubiquitin ligase complex | 33.33% (1/3) | 6.5 | 0.011012 | 0.029475 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 33.33% (1/3) | 6.5 | 0.011012 | 0.029475 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 33.33% (1/3) | 6.47 | 0.01124 | 0.029641 |
GO:0043170 | macromolecule metabolic process | 100.0% (3/3) | 2.16 | 0.011184 | 0.029712 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 33.33% (1/3) | 6.45 | 0.011392 | 0.029822 |
GO:0044770 | cell cycle phase transition | 33.33% (1/3) | 6.42 | 0.011621 | 0.030198 |
GO:1901989 | positive regulation of cell cycle phase transition | 33.33% (1/3) | 6.34 | 0.012306 | 0.031071 |
GO:0070918 | small regulatory ncRNA processing | 33.33% (1/3) | 6.35 | 0.01223 | 0.031099 |
GO:0009880 | embryonic pattern specification | 33.33% (1/3) | 6.36 | 0.012154 | 0.031128 |
GO:2000031 | regulation of salicylic acid mediated signaling pathway | 33.33% (1/3) | 6.37 | 0.012078 | 0.031157 |
GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 33.33% (1/3) | 6.31 | 0.012535 | 0.031205 |
GO:0000932 | P-body | 33.33% (1/3) | 6.32 | 0.012458 | 0.031234 |
GO:0022626 | cytosolic ribosome | 33.33% (1/3) | 6.22 | 0.013372 | 0.033057 |
GO:0044248 | cellular catabolic process | 66.67% (2/3) | 3.27 | 0.013621 | 0.033442 |
GO:0010720 | positive regulation of cell development | 33.33% (1/3) | 6.16 | 0.013904 | 0.033672 |
GO:2001233 | regulation of apoptotic signaling pathway | 33.33% (1/3) | 6.16 | 0.013904 | 0.033672 |
GO:0052548 | regulation of endopeptidase activity | 33.33% (1/3) | 6.14 | 0.014132 | 0.033993 |
GO:0051345 | positive regulation of hydrolase activity | 33.33% (1/3) | 6.09 | 0.014588 | 0.034855 |
GO:1901800 | positive regulation of proteasomal protein catabolic process | 33.33% (1/3) | 6.08 | 0.01474 | 0.034983 |
GO:0008283 | cell population proliferation | 33.33% (1/3) | 6.05 | 0.014968 | 0.035057 |
GO:0009966 | regulation of signal transduction | 66.67% (2/3) | 3.2 | 0.014921 | 0.035178 |
GO:0030111 | regulation of Wnt signaling pathway | 33.33% (1/3) | 6.03 | 0.015196 | 0.035358 |
GO:0051235 | maintenance of location | 33.33% (1/3) | 6.01 | 0.015424 | 0.035425 |
GO:0003713 | transcription coactivator activity | 33.33% (1/3) | 6.02 | 0.015348 | 0.03548 |
GO:1901575 | organic substance catabolic process | 66.67% (2/3) | 3.16 | 0.015787 | 0.036027 |
GO:0031396 | regulation of protein ubiquitination | 33.33% (1/3) | 5.96 | 0.015956 | 0.036179 |
GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 33.33% (1/3) | 5.93 | 0.016335 | 0.036806 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 33.33% (1/3) | 5.91 | 0.016487 | 0.036914 |
GO:0016477 | cell migration | 33.33% (1/3) | 5.88 | 0.016866 | 0.037528 |
GO:0010646 | regulation of cell communication | 66.67% (2/3) | 3.09 | 0.017466 | 0.037684 |
GO:0042788 | polysomal ribosome | 33.33% (1/3) | 5.81 | 0.017701 | 0.037734 |
GO:0016032 | viral process | 33.33% (1/3) | 5.84 | 0.017398 | 0.037765 |
GO:0052547 | regulation of peptidase activity | 33.33% (1/3) | 5.84 | 0.017398 | 0.037765 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 33.33% (1/3) | 5.82 | 0.017625 | 0.037798 |
GO:0080134 | regulation of response to stress | 66.67% (2/3) | 3.07 | 0.017946 | 0.037802 |
GO:0030674 | protein-macromolecule adaptor activity | 33.33% (1/3) | 5.8 | 0.017853 | 0.037831 |
GO:0023051 | regulation of signaling | 66.67% (2/3) | 3.1 | 0.017223 | 0.037847 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 66.67% (2/3) | 3.1 | 0.017212 | 0.038058 |
GO:0007018 | microtubule-based movement | 33.33% (1/3) | 5.74 | 0.018535 | 0.038814 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 33.33% (1/3) | 5.73 | 0.018687 | 0.038903 |
GO:0007005 | mitochondrion organization | 33.33% (1/3) | 5.68 | 0.019444 | 0.039108 |
GO:2001020 | regulation of response to DNA damage stimulus | 33.33% (1/3) | 5.68 | 0.019444 | 0.039108 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 33.33% (1/3) | 5.7 | 0.019066 | 0.039461 |
GO:0045732 | positive regulation of protein catabolic process | 33.33% (1/3) | 5.69 | 0.019293 | 0.039473 |
GO:0031325 | positive regulation of cellular metabolic process | 66.67% (2/3) | 3.01 | 0.019433 | 0.039533 |
GO:0090304 | nucleic acid metabolic process | 66.67% (2/3) | 3.01 | 0.019282 | 0.039679 |
GO:0010604 | positive regulation of macromolecule metabolic process | 66.67% (2/3) | 2.99 | 0.019855 | 0.03971 |
GO:0048870 | cell motility | 33.33% (1/3) | 5.64 | 0.019974 | 0.039726 |
GO:0009056 | catabolic process | 66.67% (2/3) | 2.97 | 0.020484 | 0.040289 |
GO:0090068 | positive regulation of cell cycle process | 33.33% (1/3) | 5.58 | 0.020732 | 0.04033 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 33.33% (1/3) | 5.6 | 0.020429 | 0.040404 |
GO:0061136 | regulation of proteasomal protein catabolic process | 33.33% (1/3) | 5.59 | 0.020656 | 0.040404 |
GO:0035361 | Cul8-RING ubiquitin ligase complex | 33.33% (1/3) | 12.08 | 0.00023 | 0.040982 |
GO:0051759 | sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation | 33.33% (1/3) | 12.08 | 0.00023 | 0.040982 |
GO:0060284 | regulation of cell development | 33.33% (1/3) | 5.55 | 0.021186 | 0.04099 |
GO:0060090 | molecular adaptor activity | 33.33% (1/3) | 5.54 | 0.021337 | 0.041059 |
GO:0006807 | nitrogen compound metabolic process | 100.0% (3/3) | 1.84 | 0.021806 | 0.041513 |
GO:0044260 | cellular macromolecule metabolic process | 66.67% (2/3) | 2.93 | 0.021707 | 0.041547 |
GO:2001141 | regulation of RNA biosynthetic process | 66.67% (2/3) | 2.88 | 0.022989 | 0.042625 |
GO:1903506 | regulation of nucleic acid-templated transcription | 66.67% (2/3) | 2.88 | 0.022964 | 0.042801 |
GO:0000209 | protein polyubiquitination | 33.33% (1/3) | 5.44 | 0.022849 | 0.042812 |
GO:0033044 | regulation of chromosome organization | 33.33% (1/3) | 5.45 | 0.022698 | 0.042982 |
GO:0006355 | regulation of DNA-templated transcription | 66.67% (2/3) | 2.89 | 0.022838 | 0.043017 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 33.33% (1/3) | 5.39 | 0.02368 | 0.04368 |
GO:0045862 | positive regulation of proteolysis | 33.33% (1/3) | 5.38 | 0.023831 | 0.043732 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 33.33% (1/3) | 5.37 | 0.024058 | 0.043921 |
GO:0050794 | regulation of cellular process | 100.0% (3/3) | 1.78 | 0.024862 | 0.045157 |
GO:0009893 | positive regulation of metabolic process | 66.67% (2/3) | 2.79 | 0.026081 | 0.047131 |
GO:1900150 | regulation of defense response to fungus | 33.33% (1/3) | 5.23 | 0.026322 | 0.047326 |
GO:0051252 | regulation of RNA metabolic process | 66.67% (2/3) | 2.75 | 0.027475 | 0.04915 |
GO:0140297 | DNA-binding transcription factor binding | 33.33% (1/3) | 5.14 | 0.028055 | 0.049938 |